Mayo Clinic Talks cover image

Update in the Management of Hyperlipidemia

Mayo Clinic Talks

00:00

Inclisiran: twice-yearly PCSK9-silencing option

Stephen explains inclisiran (Leqvio) as an siRNA PCSK9 agent given every six months alongside statins or ezetimibe.

Play episode from 08:11
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app